TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
RPH Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
329,395
|
230,801
|
179,807 |
Financial expenses |
32,078
|
17,903
|
21,276 |
Earnings before taxes |
44,425
|
37,196
|
50,114 |
EBITDA |
109,303
|
74,522
|
53,698 |
Total assets |
320,128
|
300,680
|
387,616 |
Current assets |
108,288
|
94,723
|
219,358 |
Current liabilities |
278,738
|
255,287
|
330,678 |
Equity capital |
38,468
|
42,471
|
51,199 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
12.0%
|
14.1%
|
13.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.5%
|
16.1%
|
27.9% |
Return on assets (ROA) |
23.9%
|
18.3%
|
18.4% |
Current ratio |
38.8%
|
37.1%
|
66.3% |
Return on equity (ROE) |
115.5%
|
87.6%
|
97.9% |
Change turnover |
98,594
|
50,994
|
39,317 |
Change turnover % |
43%
|
28%
![]() |
28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.